Gossamer Bio, Inc. (GOSS) Dividend History

Company News

• Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

  The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.

  GlobeNewswire Inc.

  Featured Companies: ABBV CPIX INSM JNJ KNSA LQDA MRK TENX THC UTHR
• XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

  XOMA Royalty Corporation has acquired Pulmokine Inc. for $20 million, adding the royalty and milestone interest in seralutinib, a Phase 3 asset being studied for pulmonary arterial hypertension, to its portfolio.

  Benzinga

  Featured Companies: XOMA XOMAO XOMAP
• Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says

  Oppenheimer initiated coverage on Gossamer Bio Inc (NASDAQ:GOSS), a clinical-stage biopharmaceutical company, with an Outperform rating and a price target of $9. Gossamer Bio is focused on developing and commercializing seralutinib for pulmonary arterial hypertension. It stands out with its clean long-term safety profile, Oppenheimer said. Competitors like Merck & Co Inc’s (NYSE:MRK) Winrevair require frequent monitoring for hemoglobin increases, thrombocytopenia, and gastrointestinal bleeding. It may require dose reductions or drug holidays. In May, Gossamer Bio and Italy-based Chiesi Farmaceutici S.p.A entered a global collaboration and license agreement to develop and commercialize seralutinib. Following the readout of the Phase 2 TORREY Study in patients with PAH, ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: MRK
• Wall Street Breakfast: The Week Ahead

  This article highlights upcoming events in the financial world, including quarterly earnings reports, IPOs, investor events, and market volatility updates.

  Seeking Alpha

  Featured Companies: ADI AI ALB AMC AMGN AS ASC AZO BAH BKE CHTR CRNC DELL ELAB ELF ETSY HUMA INTC INTU KMX KRYS LOAR LOW M MDT MRX MSFT NCI NCLH NVDA PANW PARA QCOM RBRK RL RYI SNOW TD TGT TJX TOL TSLA WDAY WOOF ZETA ZM
• Should You Buy Gossamer Bio (GOSS) After Golden Cross?

  Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

  Zacks Investment Research